Return to Special Authority drug list
Generic name |
ustekinumab |
||
Brand |
Strength |
Form |
|
Wezlana™ | 90 mg/1 mL 130 mg/26 mL (5 mg/mL) |
pre-filled, single-use syringe for subcutaneous injection single-use vial for intravenous infusion |
Special Authority criteria |
Approval period |
---|---|
InitialFor the treatment of adult patients with moderate to severe ulcerative colitis when ALL of the following criteria are met:
AND
AND
AND
|
12 weeks |
RenewalFor the continued treatment of adult patients with moderate to severe ulcerative colitis when ALL of the following criteria are met:
AND
|
1 year |